Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers
Authors:
- Dunia HatabahDHDunia Hatabah
- Sneh Lata GuptaSGSneh Lata Gupta
- Grace MantusGMGrace Mantus
- Patrick SullivanPSPatrick Sullivan
- Stacy HeilmanSHStacy Heilman
- Andres Camacho-GonzalezACAndres Camacho-Gonzalez
- Deborah LeakeDLDeborah Leake
- Mimi LeMLMimi Le
- Mark GriffithsMGMark Griffiths
- Carson NorwoodCNCarson Norwood
- Samuel ShihSSSamuel Shih
- Rawan KormanRKRawan Korman
Open Access
Abstract
Background: Vaccines against COVID-19 target the spike protein. There is minimal information on longitudinal COVID-19 immune profiling in recovered versus naïve and vaccinated versus non-vaccinated healthcare workers (HCWs). Methods: This is a prospective longitudinal observational cohort of pediatric HCWs (pHCWs) conducted during 2020–2022 at an academic center, exploring the impact of COVID-19 vaccination on immunoglobulin G (IgG) antibody titers over time and cross-reactivity with other coronaviruses, including SARS-CoV-1, MERS-CoV, and seasonal coronaviruses (HCoV-HKU1 and HCoV-OC43). Results: A total of 642 pHCWs initially enrolled, and 337 participants had repeat IgG titers measured post-vaccine and post-booster. Most participants were female, median age range of 31–40 years. Anti-spike was higher in all vaccinated individuals versus non-vaccinated (p < 0.0001) and naïve versus infected (p < 0.0001). A single dose of vaccine was sufficient to attain maximum titers in recovered participants versus naïve who received both doses of vaccine. Anti-spike titers dropped significantly at 9 months after the primary series, whereas sustained anti-spike titers were observed at 9 months post-booster. Conclusions: All vaccinated pHCWs developed antibodies to spike. COVID-19 infection and/or vaccination yielded antibodies that cross-reacted to SARS-CoV-1, MERS-CoV, HCoV-HKU1, and HCoV-OC43. Anti-spike titers were more durable post-booster compared to the primary series. Longitudinal immune profiling of COVID-19 responses provides vital data to shape public health policies, optimize vaccine strategies, and strengthen pandemic preparedness.Keywords
Funding Information
- Wilbur and Hilda Glenn Family Foundation (K24AT009893, K23HL173694)
- Michael and Natalia Beinenson (K24AT009893, K23HL173694)
- Emory University Woodruff Health Sciences Center Synergy Award (K24AT009893, K23HL173694)
- Scott Hudgens Family Foundation (K24AT009893, K23HL173694)
- NIH/NCCIH (K24AT009893, K23HL173694)
- NIH/NHLBI (K24AT009893, K23HL173694)
This publication has 46 references indexed in Scilit:
- Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategyHeliyon, 2024
- The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional studyAmerican Journal of Infection Control, 2023
- Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron InfectionJAMA Network Open, 2022
- Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant PeriodJAMA, 2022
- Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19Cell Reports, 2021
- Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New YorkJAMA Pediatrics, 2021
- Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern FranceEBioMedicine, 2021
- Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adultsClinical Immunology, 2021
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2JAMA, 2021
- COVID-19 and healthcare workers: A systematic review and meta-analysisInternational Journal of Infectious Diseases, 2021